Patents by Inventor Thomas Aldrich

Thomas Aldrich has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20210009714
    Abstract: Recombinant cell surface capture proteins and detection molecules that are useful for isolating and detecting cells that produce a secreted heterodimeric protein of interest (POI) that has an immunoglobulin CH3 domain and/or substituted CH3 domain are provided. Recombinant cell surface capture proteins and detection molecules that isolate and detect bispecific antibodies are also provided. The invention also provides recombinant antigen-binding proteins that are capable of recognizing and binding to proteins of interest that contain a CH3 domain and/or a modified CH3 domain, such as a CH3 domain with or without amino acid substitutions at H95 and Y96 (IMGT).
    Type: Application
    Filed: September 18, 2020
    Publication date: January 14, 2021
    Inventors: Dipali Deshpande, Gang Chen, Darya Burakov, James Fandl, Thomas Aldrich, Vishal Kamat
  • Patent number: 10238118
    Abstract: The disclosure describes fungal organisms and preparations useful for inhibiting infection by Xylella sp. and in the treatment of Pierce's Disease.
    Type: Grant
    Filed: September 2, 2016
    Date of Patent: March 26, 2019
    Assignee: The Regents of the University of California
    Inventors: Philippe Rolshausen, Mary Caroline Roper, Katherine Maloney, Thomas Aldrich
  • Publication number: 20180118852
    Abstract: Recombinant cell surface capture proteins and detection molecules that are useful for isolating and detecting cells that produce a secreted heterodimeric protein of interest (POI) that has an immunoglobulin CH3 domain and/or substituted CH3 domain are provided. Recombinant cell surface capture proteins and detection molecules that isolate and detect bispecific antibodies are also provided. The invention also provides recombinant antigen-binding proteins that are capable of recognizing and binding to proteins of interest that contain a CH3 domain and/or a modified CH3 domain, such as a CH3 domain with or without amino acid substitutions at H95 and Y96 (IMGT).
    Type: Application
    Filed: September 11, 2017
    Publication date: May 3, 2018
    Inventors: Dipali Deshpande, Gang Chen, Darya Burakov, James Fandl, Thomas Aldrich, Vishal Kamat
  • Patent number: 9758592
    Abstract: Recombinant cell surface capture proteins and detection molecules that are useful for isolating and detecting cells that produce a secreted heterodimeric protein of interest (POI) that has an immunoglobulin CH3 domain and/or substituted CH3 domain are provided. Recombinant cell surface capture proteins and detection molecules that isolate and detect bispecific antibodies are also provided. The invention also provides recombinant antigen-binding proteins that are capable of recognizing and binding to proteins of interest that contain a CH3 domain and/or a modified CH3 domain, such as a CH3 domain with or without amino acid substitutions at H95 and Y96 (IMGT).
    Type: Grant
    Filed: November 14, 2013
    Date of Patent: September 12, 2017
    Assignee: Regeneron Pharmaceuticals, Inc.
    Inventors: Dipali Deshpande, Gang Chen, Darya Burakov, James Fandl, Thomas Aldrich, Vishal Kamat
  • Publication number: 20170241887
    Abstract: A method of detecting and isolating cells that produce a secreted protein of interest (POI) that has an immunoglobulin CH3 domain and/or substituted CH3 domain, comprising: a) constructing a cell line transiently or stably expressing a cell surface capture molecule, which binds the POI, by transfecting the cell line with a nucleic acid that encodes such cell surface capture molecule; b) transfecting said cell simultaneously or subsequently with a second nucleic acid that encodes a POI wherein such POI is secreted; c) detecting the surface-displayed POI by contacting the cells with a detection molecule, which binds the POI; and d) isolating cells based on the detection molecule.
    Type: Application
    Filed: February 27, 2017
    Publication date: August 24, 2017
    Inventors: James P. Fandl, Gang Chen, Neil Stahl, George D. Yancopoulos, Dipali Deshpande, Darya Burakov, Thomas Aldrich, Vishal Kamat
  • Publication number: 20140134719
    Abstract: Recombinant cell surface capture proteins and detection molecules that are useful for isolating and detecting cells that produce a secreted heterodimeric protein of interest (POI) that has an immunoglobulin CH3 domain and/or substituted CH3 domain are provided. Recombinant cell surface capture proteins and detection molecules that isolate and detect bispecific antibodies are also provided. The invention also provides recombinant antigen-binding proteins that are capable of recognizing and binding to proteins of interest that contain a CH3 domain and/or a modified CH3 domain, such as a CH3 domain with or without amino acid substitutions at H95 and Y96 (IMGT).
    Type: Application
    Filed: November 14, 2013
    Publication date: May 15, 2014
    Applicant: Regeneron Pharmaceuticals, Inc.
    Inventors: DIPALI DESHPANDE, GANG CHEN, DARYA BURAKOV, JAMES FANDL, THOMAS ALDRICH, VISHAL KAMAT
  • Publication number: 20140072980
    Abstract: A method of detecting and isolating cells that produce a secreted protein of interest (POI) that has an immunoglobulin CH3 domain and/or substituted CH3 domain, comprising: a) constructing a cell line transiently or stably expressing a cell surface capture molecule, which binds the POI, by transfecting the cell line with a nucleic acid that encodes such cell surface capture molecule; b) transfecting said cell simultaneously or subsequently with a second nucleic acid that encodes a POI wherein such POI is secreted; c) detecting the surface-displayed POI by contacting the cells with a detection molecule, which binds the POI; and d) isolating cells based on the detection molecule.
    Type: Application
    Filed: November 14, 2013
    Publication date: March 13, 2014
    Applicant: Regeneron Pharmaceuticals, Inc.
    Inventors: JAMES P. FANDL, GANG CHEN, NEIL STAHL, GEORGE D. YANCOPOULOS, DIPALI DESHPANDE, DARYA BURAKOV, THOMAS ALDRICH, VISHAL KAMAT
  • Publication number: 20140072979
    Abstract: A method of detecting and isolating cells that produce a secreted protein of interest (POI) that has an immunoglobulin CH3 domain and/or substituted CH3 domain, comprising: a) constructing a cell line transiently or stably expressing a cell surface capture molecule, which binds the POI, by transfecting the cell line with a nucleic acid that encodes such cell surface capture molecule; b) transfecting said cell simultaneously or subsequently with a second nucleic acid that encodes a POI wherein such POI is secreted; c) detecting the surface-displayed POI by contacting the cells with a detection molecule, which binds the POI; and d) isolating cells based on the detection molecule.
    Type: Application
    Filed: November 14, 2013
    Publication date: March 13, 2014
    Applicant: Regeneron Pharmaceuticals, Inc.
    Inventors: JAMES P. FANDL, GANG CHEN, NEIL STAHL, GEORGE D. YANCOPOULOS, DIPALI DESHPANDE, DARYA BURAKOV, THOMAS ALDRICH, VISHAL KAMAT
  • Publication number: 20050158829
    Abstract: A fusion polypeptide comprising (A)x—M—(A?)y, wherein A and A? are each polypeptides capable of binding a target receptor. The fusion polypeptides of the invention form multimeric proteins which activate the target receptor. A and A? may be each be an antibody or fragment derived from an antibody specific for a target receptor, such as the same or different ScFv fragmetns, and/or a ligand or ligand fragment or derivative capable of binding the target protein, M is a multimerizing component, and X and Y are independently a number between 1-10.
    Type: Application
    Filed: January 14, 2005
    Publication date: July 21, 2005
    Inventors: James Fandl, Gang Chen, Nicholas Papadopoulos, Thomas Aldrich
  • Patent number: 5643755
    Abstract: The present invention provides for TIE-2 ligand substantially free of other proteins. The invention also provides for an isolated nucleic acid molecule encoding TIE-2 ligand. In addition, the invention provides for a receptor body which specifically binds TIE-2 ligand. The invention also provides an antibody which specifically binds TIE-2 ligand. The invention further provides for therapeutic compositions as well as a method of blocking blood vessel growth, a method of promoting neovascularization and a method of promoting the growth or differentiation of a cell expressing the TIE-2 receptor.
    Type: Grant
    Filed: October 7, 1994
    Date of Patent: July 1, 1997
    Assignee: Regeneron Pharmaceuticals Inc.
    Inventors: Samuel Davis, Thomas Aldrich, George D. Yancopoulos
  • Patent number: D244425
    Type: Grant
    Filed: March 24, 1975
    Date of Patent: May 24, 1977
    Assignee: The Clorox Company
    Inventors: Thomas Aldrich, Albert Torongo
  • Patent number: D271790
    Type: Grant
    Filed: January 16, 1981
    Date of Patent: December 13, 1983
    Assignee: Thermo-Tech Corp.
    Inventor: Thomas Aldrich
  • Patent number: D342678
    Type: Grant
    Filed: April 1, 1992
    Date of Patent: December 28, 1993
    Assignee: S. C. Johnson & Son, Inc.
    Inventors: Jim Warner, Thomas Aldrich
  • Patent number: D382809
    Type: Grant
    Filed: February 15, 1996
    Date of Patent: August 26, 1997
    Assignee: Societe des Produits Nestle S.A.
    Inventors: Thomas Aldrich, Douglas H. Novakoski, James Warner
  • Patent number: D382810
    Type: Grant
    Filed: February 15, 1996
    Date of Patent: August 26, 1997
    Assignee: Societe des Produits Nestle S.A.
    Inventors: Thomas Aldrich, Douglas H. Novakoski, James Warner